Contraceptive Patch from Actavis Plc Rejected by FDA

Contraceptive Patch from Actavis Plc Rejected by FDA

US FDA has rejected the New Drug Application for transdermal contraceptive patch for women by Actavis Plc. The US regulator has asked the company to provide more data to support the claims for the patch. Ireland-based generic drug market Actavis said that the company will closely work with FDA and address their concerns.


Popular Stories

Harley-Davidson to turn 8 Dyna motorbikes into new Softail bikes

Betting big on cruisers, the luxury motorcycle... Read More

Uber’s net loss declines as ride bookings grow

Uber Technologies reported lower loss by nearly 9... Read More

Samsung Galaxy Note 8 facing challenges on multiple fronts

The Samsung Galaxy Note 8 is facing an increasingly... Read More

Leaked reports reveal more about new BMW M5

Luxury carmaker BMW’s next-generation M5 car will... Read More